1. Home
  2. GHY vs CGC Comparison

GHY vs CGC Comparison

Compare GHY & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PGIM Global High Yield Fund Inc.

GHY

PGIM Global High Yield Fund Inc.

N/A

Current Price

$10.92

Market Cap

472.3M

Sector

Finance

ML Signal

N/A

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.87

Market Cap

389.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GHY
CGC
Founded
2012
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.3M
389.2M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GHY
CGC
Price
$10.92
$0.87
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $1.82
AVG Volume (30 Days)
197.0K
★ 1.8M
Earning Date
01-01-0001
11-06-2026
Dividend Yield
★ 10.58%
N/A
EPS Growth
N/A
★ 84.17
EPS
★ N/A
N/A
Revenue
N/A
★ $12,759,000.00
Revenue This Year
N/A
$21.39
Revenue Next Year
N/A
$8.33
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.85
$0.84
52 Week High
$12.96
$2.38

Technical Indicators

Market Signals
Indicator
GHY
CGC
Relative Strength Index (RSI) 34.37 37.93
Support Level N/A $0.85
Resistance Level $12.07 $0.98
Average True Range (ATR) 0.15 0.03
MACD -0.01 -0.00
Stochastic Oscillator 34.00 16.31

Price Performance

Historical Comparison
GHY
CGC

About GHY PGIM Global High Yield Fund Inc.

PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: